Optimal Use of Serum Leucine-Rich Alpha-2 Glycoprotein as a Biomarker for Small Bowel Lesions of Crohn’s Disease

INTRODUCTION: A large proportion of small bowel lesions in Crohn’s disease (CD) may exist beyond the reach of ileocolonoscopy and there is no gold standard imaging modality to screen them, suggesting the need for optimal biomarkers. We aimed to compare the usefulness of C-reactive protein (CRP), fae...

Descripción completa

Detalles Bibliográficos
Autores principales: Asonuma, Kunio, Kobayashi, Taku, Kikkawa, Nao, Nakano, Masaru, Sagami, Shintaro, Morikubo, Hiromu, Miyatani, Yusuke, Hojo, Aya, Fukuda, Tomohiro, Hibi, Toshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315012/
https://www.ncbi.nlm.nih.gov/pubmed/37404381
http://dx.doi.org/10.1159/000530825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315012/
https://www.ncbi.nlm.nih.gov/pubmed/37404381
http://dx.doi.org/10.1159/000530825

Ejemplares similares